TRAVERE THERAPEUTICS INC

Ticker: TVTX CUSIP: 89422G107 Class: Common Stock

Eversept Partners, LP's Holding History (CIK: 0001697013)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 1,174,968 Value ($000) $44,896 Avg Close $32.52 Range $23.22 - $42.13

Q3 2025

Shares 1,417,204 Value ($000) $33,871 Avg Close $18.80 Range $14.36 - $28.69

Q2 2025

Shares 1,315,033 Value ($000) $19,462 Avg Close $16.57 Range $12.91 - $22.07

Q1 2025

Shares 816,254 Value ($000) $14,627 Avg Close $20.30 Range $16.80 - $25.29

Q4 2024

Shares 490,296 Value ($000) $8,541 Avg Close $17.69 Range $13.24 - $20.33

Q3 2024

Shares 869,913 Value ($000) $12,170 Avg Close $10.42 Range $7.72 - $15.36

Q2 2024

Shares 1,091,165 Value ($000) $8,969 Avg Close $6.73 Range $5.12 - $8.38

Q1 2024

Shares 955,618 Value ($000) $7,368 Avg Close $8.44 Range $7.11 - $10.27

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	1,174,968	$44,896	$32.52	$23.22 - $42.13
Q3 2025	1,417,204	$33,871	$18.80	$14.36 - $28.69
Q2 2025	1,315,033	$19,462	$16.57	$12.91 - $22.07
Q1 2025	816,254	$14,627	$20.30	$16.80 - $25.29
Q4 2024	490,296	$8,541	$17.69	$13.24 - $20.33
Q3 2024	869,913	$12,170	$10.42	$7.72 - $15.36
Q2 2024	1,091,165	$8,969	$6.73	$5.12 - $8.38
Q1 2024	955,618	$7,368	$8.44	$7.11 - $10.27